EGRX

Eagle Pharmaceuticals, Inc.

Healthcare · USD

Set alert

Price alert · EGRX

All alert types
0.25 USD 0.00 0.00%
As of Feb 5, 2026
1.50 Day range 1.50
0.001 52-week range 3.94
YTD
-64.29%
1 year
-89.36%
Open
1.50
Prev close
0.25
Mkt cap
3.29M
Vol
100
Avg vol
1.63K
EPS
1.73
P/E
0.14
Div yield
0.00%
More statistics
Low
1.50
High
1.50
Forward P/E
0.28
Beta
0.62
Short ratio
3.91
Inst. own
80.90%
Dividend
0.00
Ex-div date
Earnings
Oct 1, 2024
50-d avg
1.49
200-d avg
4.03
1y target
0.00

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for EGRX has not been loaded yet. Try again in a moment.

Period ending Jun 30, 2023 · select a line to chart its history

Revenue & Expenses

Revenue by
Product → Revenue: $42.99MRevenue → Gross Profit: $47.79MGross Profit → Net Income: $5.16MGross Profit → Selling, General & Admin: $27.65MGross Profit → Research & Development: $9.83MRevenue → Cost of Revenue: $16.86MGross Profit → Other Expenses: $1.01MGross Profit → Income Tax: $4.13MRoyalty → Revenue: $21.65MGross Profit$47.79MCost of Revenue$16.86MNet Income$5.16MSelling, General & Admin$27.65MResearch & Development$9.83MOther Expenses$1.01MIncome Tax$4.13MRevenue$64.65MProduct$42.99MRoyalty$21.65M

Income statement

EGRX quarterly income statement
64.65M
64.65M
16.86M
47.79M
37.48M
9.83M
27.65M
10.30M
1.45M
4.13M
5.16M
5.16M
5.16M
5.16M
0.39
0.39
0.39
10.75M
10.75M
13.09M
13.15M

Balance sheet

EGRX quarterly balance sheet
15.35M
15.35M
115.14M
187.25M
1.01M
404.82M
8.30M
70.19M
86.63M
61.90M
152.78M
122.42M
-1.11M
252.04M
252.04M
217.57M
70.19M
152.44M
42.48M
66.15M
15.84M
30.71M

Cash flow

EGRX quarterly cash flow
5.89M
-6.41M
-6.54M
-6.00K
-6.25M
-6.00K
-126.00K
4.19M